FDAnews
www.fdanews.com/articles/132012-amgen-said-to-consider-actelion-takeover-bid-to-gain-rare-disease-drugs

Amgen Said to Consider Actelion Takeover Bid to Gain Rare Disease Drugs

November 17, 2010
Amgen Inc., the world’s largest biotechnology company, is considering a takeover offer for Actelion Ltd. to gain new medicines for rare diseases, and may approach the Swiss drugmaker as early as this week, said two people with knowledge of the matter.
Bloomberg